{"id":7392,"date":"2024-06-06T16:54:00","date_gmt":"2024-06-06T15:54:00","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=7392"},"modified":"2024-06-06T16:54:00","modified_gmt":"2024-06-06T15:54:00","slug":"anvisa-approves-regulations-for-biosimilars","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/","title":{"rendered":"Anvisa approves regulations for biosimilars"},"content":{"rendered":"<\/p>\n

Anvisa approves regulations for biosimilars<\/strong><\/p>\n

At a meeting of the Collegiate Board of Directors, Anvisa (the National Health Surveillance Agency) approved the new regulations for registering biosimilar medicines. The regulation dispenses with some specific steps and studies, when technically feasible, promoting a transparent and predictable regulatory environment for the sector. Read more here<\/span><\/a><\/p>\n

If you need more information on regulatory issues in the pharmaceutical industry and healthcare, ELS can certainly help.<\/p>\n

Please do not hesitate to c<\/span>ontact your local ELS consultant<\/a>\u00a0or via email info@elssolutions.pt<\/p>\n

\n","protected":false},"excerpt":{"rendered":"

New standard eases requirements and simplifies product development, promoting a transparent regulatory environment.<\/p>\n","protected":false},"author":9,"featured_media":7382,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[54,61],"tags":[62],"class_list":["post-7392","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-news","tag-news"],"yoast_head":"\nRegulations for biosimilars approved by Anvisa<\/title>\n<meta name=\"description\" content=\"New standard eases requirements and simplifies product development, promoting a transparent regulatory environment.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa approves regulations for biosimilars\" \/>\n<meta property=\"og:description\" content=\"New standard eases requirements and simplifies product development, promoting a transparent regulatory environment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-06T15:54:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Anvisa approves regulations for biosimilars\",\"datePublished\":\"2024-06-06T15:54:00+00:00\",\"dateModified\":\"2024-06-06T15:54:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/\"},\"wordCount\":815,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg\",\"keywords\":[\"News\"],\"articleSection\":[\"General\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/\",\"url\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/\",\"name\":\"Regulations for biosimilars approved by Anvisa\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg\",\"datePublished\":\"2024-06-06T15:54:00+00:00\",\"dateModified\":\"2024-06-06T15:54:00+00:00\",\"description\":\"New standard eases requirements and simplifies product development, promoting a transparent regulatory environment.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg\",\"width\":1200,\"height\":600,\"caption\":\"Biosimilar medicines that are part of the standard\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa approves regulations for biosimilars\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/en\/#website\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regulations for biosimilars approved by Anvisa","description":"New standard eases requirements and simplifies product development, promoting a transparent regulatory environment.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Anvisa approves regulations for biosimilars","og_description":"New standard eases requirements and simplifies product development, promoting a transparent regulatory environment.","og_url":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2024-06-06T15:54:00+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg","type":"image\/jpeg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Anvisa approves regulations for biosimilars","datePublished":"2024-06-06T15:54:00+00:00","dateModified":"2024-06-06T15:54:00+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/"},"wordCount":815,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg","keywords":["News"],"articleSection":["General","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/","url":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/","name":"Regulations for biosimilars approved by Anvisa","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg","datePublished":"2024-06-06T15:54:00+00:00","dateModified":"2024-06-06T15:54:00+00:00","description":"New standard eases requirements and simplifies product development, promoting a transparent regulatory environment.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/06\/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg","width":1200,"height":600,"caption":"Biosimilar medicines that are part of the standard"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/en\/anvisa-approves-regulations-for-biosimilars\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anvisa approves regulations for biosimilars"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/en\/#website","url":"https:\/\/els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=7392"}],"version-history":[{"count":1,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7392\/revisions"}],"predecessor-version":[{"id":7393,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/7392\/revisions\/7393"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media\/7382"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=7392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/categories?post=7392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/tags?post=7392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}